NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

CUSIP: 67001K202

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM NEW
Total 13F shares
7,758,418
Share change
-1,775,475
Total reported value
$5,454,000
Price per share
$0.70
Number of holders
5
Value change
-$1,304,348
Number of buys
2
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVELION THERAPEUTICS INC - COM NEW (NVLNF) as of Q4 2019

As of 31 Dec 2019, NOVELION THERAPEUTICS INC - COM NEW (NVLNF) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,758,418 shares. The largest 5 holders included Stonepine Capital Management, LLC, EdgePoint Investment Group Inc., Knott David M, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and FRANKLIN STREET ADVISORS INC /NC. This page lists 5 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.